Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration

被引:5
|
作者
Cabral, Silvia [1 ]
Bonfim, Cristine [2 ,3 ]
Oliveira, Rosalira [2 ]
Oliveira, Paula [4 ,5 ]
Guimaraes, Terezinha [4 ]
Brandao, Eduardo [5 ]
Aguiar-Santos, Ana Maria [5 ]
Medeiros, Zulma [5 ,6 ]
机构
[1] Fundacao Oswaldo Cruz, Ctr Pesquisa Aggeu Magalhaes, Programa Doutorado Saude Publ, Recife, PE, Brazil
[2] Fundacao Joaquim Nabuco, Dept Pesquisa Social, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Programa Posgrad Integrada Saude Colet, Recife, PE, Brazil
[4] Secretaria Saude Olinda, Recife, PE, Brazil
[5] Fundacao Oswaldo Cruz, Ctr Pesquisa Aggeu Magalhaes, Dept Parasitol, Recife, PE, Brazil
[6] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil
关键词
Lymphatic filariasis; Control program; Mass drug administration; Systematic noncompliance; URBAN AREAS; EPIDEMIOLOGIC SITUATION; BANCROFTIAN FILARIASIS; ENDEMIC AREA; PROGRAM; ELIMINATION; COVERAGE; BRAZIL; INDIA; DISTRICT;
D O I
10.1590/S1678-9946201759023
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to investigate the epidemiological characteristics, antigenic profile, perceptions, attitudes and practices of individuals who have been systematically noncompliant in mass drug administration (MDA) campaigns targeting lymphatic filariasis, in the municipality of Olinda, State of Pernambuco, Northeastern Brazil. A pretested questionnaire was used to obtain information on socioenvironmental demographics, perceptions of lymphatic filariasis and MDA, and reasons for systematic noncompliance with treatment. A rapid immunochromatographic test (ICT) was performed during the survey to screen for filariasis. It was found that the survey subjects knew about filariasis and MDA. Filariasis was identified as a disease (86.2%) and 74.4% associated it with the presence of swelling in the legs. About 80% knew about MDA, and the main source of information was healthcare workers (68.3%). For men the main reasons for systematic noncompliance with MDA were that "the individual had not received the medication" (p=0.03) and for women "the individual either feared experiencing adverse reactions". According to the ICT, the prevalence of lymphatic filariasis was 2%. The most important causes of systematic noncompliance were not receiving the drug and fear of side-effects. For successful implementation of MDA programs, good planning, educational campaigns promoting the benefits of MDA, adoption of measures to minimize the impact of adverse effects and improvement of drug distribution logistics are needed.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Investigation of systematic noncompliance in the context of a mass drug administration program for lymphatic filariasis
    Talbot, Jeffrey
    Viall, Abigail
    Direny, Abdel
    de Rochars, Madsen Beau
    Addiss, David
    Streit, Thomas
    Mathieu, Els
    Lammie, Patrick
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 101 - 102
  • [2] The Impact of Mass Drug Administration on Lymphatic Filariasis
    Aboagye, Isaac Frimpong
    Addison, Yvonne Abena Afadua
    JOURNAL OF TROPICAL MEDICINE, 2022, 2022
  • [3] The Impact of Mass Drug Administration on Lymphatic Filariasis
    Aboagye, Isaac Frimpong
    Addison, Yvonne Abena Afadua
    JOURNAL OF TROPICAL MEDICINE, 2022, 2022
  • [4] Mass drug administration to treat lymphatic filariasis
    Ravindran, B
    LANCET, 2002, 359 (9321): : 1948 - 1948
  • [5] A MULTICENTER STUDY OF THE SAFETY OF TRIPLE DRUG MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS
    Weil, Gary J.
    Bogus, Joshua
    Dubray, Christine
    Fischer, Peter U.
    Jambulingam, P.
    King, Christopher L.
    Lemoine, Jean Frantz
    O'Brian, Katiuscia
    Robinson, Leanne J.
    Supali, Taniawati
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 239 - 239
  • [6] Albenclazole for mass drug administration to eliminate lymphatic filariasis
    Sabesan, Shanmugavelu
    LANCET INFECTIOUS DISEASES, 2006, 6 (11): : 684 - 685
  • [7] Mass drug administration to eliminate lymphatic filariasis in India
    Ramaiah, KD
    Das, PK
    TRENDS IN PARASITOLOGY, 2004, 20 (11) : 499 - 502
  • [8] COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA
    Kisoka, William J.
    Tersbol, Britt Pinkowsky
    Meyrowitsch, Dan W.
    Simonsen, Paul E.
    Mushi, Declare L.
    JOURNAL OF BIOSOCIAL SCIENCE, 2016, 48 (01) : 94 - 112
  • [9] The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya
    Kusi, Caroline
    Steinmann, Peter
    Merten, Sonja
    INFECTIOUS DISEASES OF POVERTY, 2020, 9 (01)
  • [10] The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya
    Caroline Kusi
    Peter Steinmann
    Sonja Merten
    Infectious Diseases of Poverty, 9